Literature DB >> 17485441

c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1.

Victoria H Cowling1, Celina M D'Cruz, Lewis A Chodosh, Michael D Cole.   

Abstract

c-myc is frequently amplified in breast cancer; however, the mechanism of myc-induced mammary epithelial cell transformation has not been defined. We show that c-Myc induces a profound morphological transformation in human mammary epithelial cells and anchorage-independent growth. c-Myc suppresses the Wnt inhibitors DKK1 and SFRP1, and derepression of DKK1 or SFRP1 reduces Myc-dependent transforming activity. Myc-dependent repression of DKK1 and SFRP1 is accompanied by Wnt target gene activation and endogenous T-cell factor activity. Myc-induced mouse mammary tumors have repressed SFRP1 and increased expression of Wnt target genes. DKK1 and SFRP1 inhibit the transformed phenotype of breast cancer cell lines, and DKK1 inhibits tumor formation. We propose a positive feedback loop for activation of the c-myc and Wnt pathways in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485441      PMCID: PMC1951955          DOI: 10.1128/MCB.02282-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

Review 1.  c-Myc in breast cancer.

Authors:  D J Liao; R B Dickson
Journal:  Endocr Relat Cancer       Date:  2000-09       Impact factor: 5.678

Review 2.  Wnt pathway activation: new relations and locations.

Authors:  Amy Bejsovec
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 3.  Wnt signaling in disease and in development.

Authors:  Roel Nusse
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

4.  CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.

Authors:  Felicite K Noubissi; Irina Elcheva; Neehar Bhatia; Abbas Shakoori; Andrei Ougolkov; Jianghuai Liu; Toshinari Minamoto; Jeff Ross; Serge Y Fuchs; Vladimir S Spiegelman
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

5.  WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene.

Authors:  L Xu; R B Corcoran; J W Welsh; D Pennica; A J Levine
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

Review 6.  The c-Myc target gene network.

Authors:  Chi V Dang; Kathryn A O'Donnell; Karen I Zeller; Tam Nguyen; Rebecca C Osthus; Feng Li
Journal:  Semin Cancer Biol       Date:  2006-07-25       Impact factor: 15.707

7.  Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression.

Authors:  S Y Lin; W Xia; J C Wang; K Y Kwong; B Spohn; Y Wen; R G Pestell; M C Hung
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

8.  C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance.

Authors:  S L Deming; S J Nass; R B Dickson; B J Trock
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

9.  E-cadherin repression contributes to c-Myc-induced epithelial cell transformation.

Authors:  V H Cowling; M D Cole
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

Review 10.  Mechanism of transcriptional activation by the Myc oncoproteins.

Authors:  Victoria H Cowling; Michael D Cole
Journal:  Semin Cancer Biol       Date:  2006-08-04       Impact factor: 15.707

View more
  64 in total

Review 1.  Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling.

Authors:  Caroline M Alexander; Shruti Goel; Saja A Fakhraldeen; Soyoung Kim
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-10-01       Impact factor: 10.005

Review 2.  Dickkopf1: a tumor suppressor or metastasis promoter?

Authors:  Mitchell E Menezes; Daniel J Devine; Lalita A Shevde; Rajeev S Samant
Journal:  Int J Cancer       Date:  2011-11-02       Impact factor: 7.396

3.  β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.

Authors:  Jinhua Xu; Yinghua Chen; Dezheng Huo; Andrey Khramtsov; Galina Khramtsova; Chunling Zhang; Kathleen H Goss; Olufunmilayo I Olopade
Journal:  Mol Carcinog       Date:  2015-02-08       Impact factor: 4.784

4.  The world according to MYC. Conference on MYC and the transcriptional control of proliferation and oncogenesis.

Authors:  Bernhard Lüscher; Lars-Gunnar Larsson
Journal:  EMBO Rep       Date:  2007-11-16       Impact factor: 8.807

5.  Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.

Authors:  Zeng-Quan Yang; Gang Liu; Aliccia Bollig-Fischer; Ramsi Haddad; Adi L Tarca; Stephen P Ethier
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

6.  New model systems provide insights into Myc-induced transformation.

Authors:  A R Wasylishen; A Stojanova; S Oliveri; A C Rust; A D Schimmer; L Z Penn
Journal:  Oncogene       Date:  2011-03-28       Impact factor: 9.867

Review 7.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

8.  Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction.

Authors:  Chun-Liang Lin; Jeng-Yi Wang; Jih-Yang Ko; Yu-Ting Huang; Yu-Hsia Kuo; Feng-Sheng Wang
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

9.  Wnt gene expression in human trabecular meshwork cells.

Authors:  Rajalekshmy Shyam; Xiang Shen; Beatrice Y J T Yue; Kelly K Wentz-Hunter
Journal:  Mol Vis       Date:  2010-01-28       Impact factor: 2.367

Review 10.  Key signalling nodes in mammary gland development and cancer: Myc.

Authors:  Nancy E Hynes; Tina Stoelzle
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.